TL;DR
This study provides population-based prevalence data for NMOSD in Fujian, China, during the period from 2021 to 2023, representing one of the most up-to-date estimates of NMOSD prevalence in southeastern China.
Age at diagnosis may represent a relevant clinical factor when evaluating disability burden in NMOSD and further prospective multicenter studies are warranted to better define longitudinal outcomes and prognostic factors in LO-NMOSD.
AIMS Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder. Understanding the underlying causes would help further studies on the pathogenesis and treatments. Recent interest has emerged in evaluating whether the COVID-19 pandemic and vaccination have any influence on the epidemiological patte...
BACKGROUND Autoimmune comorbidities in aquaporin-4-immunoglobulin G (AQP4-IgG)-positive neuromyelitis optica spectrum disorder (NMOSD) may be associated with increased disease severity and therapeutic challenges, yet prevalence estimates vary considerably. Some variability may reflect differences in population characte...
Background/Objectives: Idiopathic inflammatory myopathies (IIMs) are very rare, chronic, immune-mediated diseases that clinically manifest with myositis symptoms and extramuscular manifestations. The rarity of the disease makes it difficult to conduct double-blind studies, and large population-based studies are needed...
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
